G-CSF rescues the memory impairment of animal models of Alzheimer's disease

Journal of Experimental Medicine

Volumn 204, Issue 6, 2007, Pages 1273-1280

  Tsai, Kuen Jer ^a   Tsai, Yueh Chiao ^b   Shen, Che Kun James ^a,b  

^a INSTITUTE OF MOLECULAR BIOLOGY   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; AMYLOID BETA PROTEIN; BROXURIDINE; GRANULOCYTE COLONY STIMULATING FACTOR;

ACETYLCHOLINE BRAIN LEVEL; ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW; CELL TRANSFER; COGNITION; CONTROLLED STUDY; FEASIBILITY STUDY; HEMATOPOIETIC STEM CELL; MALE; MEMORY; MEMORY DISORDER; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NEUTROPENIA; NONHUMAN; PRIORITY JOURNAL;

ACETYLCHOLINE; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; BRAIN; BROMODEOXYURIDINE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; IMMUNOHISTOCHEMISTRY; INJECTIONS, SUBCUTANEOUS; MAZE LEARNING; MEMORY; MICE;

EID: 34250328767     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20062481     Document Type: Article

References (30)

1. Mattson, M.P. 2004. Pathways towards and away from Alzheimer's disease. Nature. 430:631-639.
2. Blennow, K., M.J. de Leon, and H. Zetterberg. 2006. Alzheimer's disease. Lancet. 368:387-403.
3. Kang, J., H.G. Lemaire, A. Unterbeck, J.M. Salbaum, C.L. Masters, K.H. Grzeschik, G. Multhaup, K. Beyreuther, and B. Muller-Hill. 1987. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature. 325:733-736.
4. Francis, P.T., A. Nordberg, and S.E. Arnold. 2005. A preclinical view of cholinesterase inhibitors in neuroprotection: do they provide more than symptomatic benefits in Alzheimer's disease? Trends Pharmacol. Sci. 26:104-111.
5. Schenk, D. 2002. Amyloid-beta immunotherapy for Alzheimer's disease: the end of the beginning. Nat. Rev. Neurosci. 3:824-828.
6. Citron, M. 2004. Strategies for disease modification in Alzheimer's disease. Nat. Rev. Neurosci. 5:677-685.
7. Bodine, D.M., N.E. Seidel, M.S. Gale, A.W. Nienhuis, and D. Orlic. 1994. Efficient retrovirus transduction of mouse pluripotent hematopoietic stem cells mobilized into the peripheral blood by treatment with granulocyte colony-stimulating factor and stem cell factor. Blood. 84:1482-1491.
8. Orlic, D., J. Kajstura, S. Chimenti, F. Limana, I. Jakoniuk, F. Quaini, B. Nadal-Ginard, D.M. Bodine, A. Leri, and P. Anversa. 2001. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc. Natl. Acad. Sci. USA. 98:10344-10349.
9. Sheridan, W.P., G. Morstyn, M. Wolf, A. Dodds, J. Lusk, D. Maher, J.E. Layton, M.D. Green, L. Souza, and R.M. Fox. 1989. Granulocyte colony-stimulating factor and neutrophil recovery after high-dose chemotherapy and autologous bone marrow transplantation. Lancet. 2:891-895.
10. Weaver, C.H., C.D. Buckner, K. Longin, F.R. Appelbaum, S. Rowley, K. Lilleby, J. Miser, R. Storb, J.A. Hansen, and W. Bensinger. 1993. Syngeneic transplantation with peripheral blood mononuclear cells collected after the administration of recombinant human granulocyte colony-stimulating factor. Blood. 82:1981-1984.
11. Shyu, W.C., S.Z. Lin, H.I. Yang, Y.S. Tzeng, C.Y. Pang, P.S. Yen, and H. Li. 2004. Functional recovery of stroke rats induced by granulocyte colony-stimulating factor-stimulated stem cells. Circulation. 110:1847-1854.
12. Schneider, A., C. Kruger, T. Steigleder, D. Weber, C. Pitzer, R. Laage, J. Aronowski, M.H. Maurer, N. Gassler, W. Mier, et al. 2005. The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J. Clin. Invest. 115:2083-2098.
13. Kawada, H., S. Takizawa, T. Takanashi, Y. Morita, J. Fujita, K. Fukuda, S. Takagi, H. Okano, K. Ando, and T. Hotta. 2006. Administration of hematopoietic cytokines in the subacute phase after cerebral infarction is effective for functional recovery facilitating proliferation of intrinsic neural stem/progenitor cells and transition of bone marrow-derived neuronal cells. Circulation. 113:701-710.
14. Stephan, A., S. Laroche, and S. Davis. 2001. Generation of aggregated beta-amyloid in the rat hippocampus impairs synaptic transmission and plasticity and causes memory deficits. J. Neurosci. 21:5703-5714.
15. Yan, J.J., J.Y. Cho, H.S. Kim, K.L. Kim, J.S. Jung, S.O. Huh, H.W. Suh, Y.H. Kim, and D.K. Song. 2001. Protection against beta-amyloid peptide toxicity in vivo with long-term administration of ferulic acid. Protection against beta-amyloid peptide toxicity in vivo with long-term administration of ferulic acid. Br. J. Pharmacol. 133:89-96.
16. Grigg, A.P., A.W. Roberts, H. Raunow, S. Houghton, J.E. Layton, A.W. Boyd, K.M. McGrath, and D. Maher. 1995. Optimizing dose and scheduling of filgrastim (granulocyte colony-stimulating factor) for mobilization and collection of peripheral blood progenitor cells in normal volunteers. Blood. 86:4437-4445.
17. Hsiao, K., P. Chapman, S. Nilsen, C. Eckman, Y. Harigaya, S. Younkin, F. Yang, and G. Cole. 1996. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science. 274:99-102.
18. Ashe, K.H. 2001. Learning and memory in transgenic mice modeling Alzheimer's disease. Learn. Mem. 8:301-308.
19. Brazelton, T.R., F.M.V. Rossi, G.I. Keshet, and H.M. Blau. 2000. From marrow to brain: expression of neuronal phenotypes in adult mice. Science. 290:1775-1779.
20. Chopp, M., and Y. Li. 2002. Treatment of neural injury with marrow stromal cells. Lancet Neurol. 1:92-100.
21. Majka, M., A. Janowska-Wieczorek, J. Ratajczak, K. Ehrenman, Z. Pietrzkowski, M.A. Kowalska, A.M. Gewirtz, S.G. Emerson, and M.Z. Ratajczak. 2001. Numerous growth factors, cytokines, and chemokines are secreted by human CD34(+) cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner. Blood. 97:3075-3085.
22. Williams, L.R., S. Varon, G.M. Peterson, K. Wictorin, W. Fischer, A. Bjorklund, and F.H. Gage. 1986. Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria fornix transection. Proc. Natl. Acad. Sci. USA. 83:9231-9235.
23. Ming, G.L., and H. Song. 2005. Adult neurogenesis in the mammalian central nervous system. Annu. Rev. Neurosci. 28:223-250.
24. Schabitz, W.R., R. Kollmar, M. Schwaninger, E. Juettler, J. Bardutzky, M.N. Scholzke, C. Sommer, and S. Schwab. 2003. Neuroprotective effect of granulocyte colony-stimulating factor after focal cerebral ischemia. Stroke. 34:745-751.
25. Ramirez, B.G., C. Blazquez, T. Gomez del Pulgar, M. Guzman, and M.L. de Ceballos. 2005. Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation. J. Neurosci. 25:1904-1913.
26. Janus, C., J. Pearson, J. McLaurin, P.M. Mathews, Y. Jiang, S.D. Schmidt, M.A. Chishti, P. Horne, D. Heslin, J. French, et al. 2000. A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature. 408:979-982.
27. Tsai, K.J., S.K. Chen, Y.L. Ma, W.L. Hsu, and E.H. Lee. 2002. sgk, a primary glucocorticoid-induced gene, facilitates memory consolidation of spatial learning in rats. Proc. Natl. Acad. Sci. USA. 99:3990-3995.
28. Zhang, R.L., Z.G. Zhang, L. Zhang, and M. Chopp. 2001. Proliferation and differentiation of progenitor cells in the cortex and the subventricular zone in the adult rat after focal cerebral ischemia. Neuroscience. 105:33-41.
29. Wyss-Coray, T., C. Lin, F. Yan, G.Q. Yu, M. Rohde, L. McConlogue, E. Masliah, and L. Mucke. 2001. TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice. Nat. Med. 7:612-618.
30. Kawarabayashi, T., L.H. Younkin, T.C. Saido, M. Shoji, K.H. Ashe, and S.G. Younkin. 2001. Age-dependent changes in brain, CSF, and plasma amyloid β protein in the Tg2576 transgenic mouse model of Alzheimer's disease. J. Neurosci. 21:372-381.